Spots Global Cancer Trial Database for ferumoxytol
Every month we try and update this database with for ferumoxytol cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma | NCT03347617 | Glioblastoma | Ferumoxytol Laboratory Biom... Magnetic Resona... Pembrolizumab | 18 Years - | OHSU Knight Cancer Institute | |
| A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma | NCT04900792 | Glioblastoma Glioblastoma Mu... | Ferumoxytol inj... Pharmacological... External beam r... Temozolomide | 18 Years - | University of Iowa | |
| Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases | NCT00103038 | Central Nervous... Malignant Gliom... Metastatic Mali... | 3 Tesla Magneti... Dynamic Contras... Dynamic Suscept... Ferumoxytol Gadolinium MRI-Based Angio... | 18 Years - | OHSU Knight Cancer Institute | |
| Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System | NCT03270059 | Central Nervous... Cranial Nerve D... Metastatic Mali... | Ferumoxytol Gadolinium Magnetic Resona... | 10 Years - | OHSU Knight Cancer Institute | |
| Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers | NCT02141490 | Prostate Cancer Bladder Cancer Kidney Cancer | Ferumoxytol Magnetic Resona... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma | NCT02359097 | Glioblastoma | Dynamic Suscept... Ferumoxytol Gadoteridol Magnetic Resona... | 18 Years - | OHSU Knight Cancer Institute | |
| Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy | NCT00769093 | Brain Neoplasms | Ferumoxytol | 18 Years - 75 Years | OHSU Knight Cancer Institute | |
| Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI | NCT01895829 | Head and Neck C... | Magnetic Resona... Ferumoxytol | 18 Years - | M.D. Anderson Cancer Center | |
| Pembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain Metastases | NCT03325166 | Lung Carcinoma ... Stage IV Lung N... | Ferumoxytol Laboratory Biom... Magnetic Resona... Pembrolizumab | 18 Years - | OHSU Knight Cancer Institute | |
| Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma | NCT02359097 | Glioblastoma | Dynamic Suscept... Ferumoxytol Gadoteridol Magnetic Resona... | 18 Years - | OHSU Knight Cancer Institute | |
| Ferumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate Cancer | NCT01296139 | Prostate Cancer | Ferumoxytol | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS | NCT02452216 | Brain Injury Central Nervous... Central Nervous... Central Nervous... Hemorrhagic Cer... Ischemic Cerebr... Primary Brain N... Brain Cancer Brain Tumors | Ferumoxytol Tissue Analysis Magnetic Resona... | 2 Years - | Stanford University | |
| In Vivo Characterization of Macrophages in Pediatric Patients With Malignant Brain Tumors Using Ferumoxytol-enhanced MRI | NCT03179449 | Childhood Brain... | Diagnostic (fer... Surgery Ferumoxytol Tissue Analysis | 2 Years - | Stanford University | |
| Ferumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate Cancer | NCT01296139 | Prostate Cancer | Ferumoxytol | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI | NCT01895829 | Head and Neck C... | Magnetic Resona... Ferumoxytol | 18 Years - | M.D. Anderson Cancer Center | |
| Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors | NCT00659126 | Metastatic Mali... Primary Brain N... | 3 Tesla Magneti... Dynamic Contras... Dynamic Suscept... Ferumoxytol Gadolinium High Field Stre... Susceptibility ... | 18 Years - | OHSU Knight Cancer Institute | |
| A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma | NCT04900792 | Glioblastoma Glioblastoma Mu... | Ferumoxytol inj... Pharmacological... External beam r... Temozolomide | 18 Years - | University of Iowa | |
| Diagnostic Accuracy of Ferumoxytol-Enhanced MRI for Detecting Lymph Node Metastases in Colorectal Cancer | NCT01983371 | Colorectal Canc... | Ferumoxytol Magnetic Resona... | 18 Years - | University of Vermont | |
| Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas | NCT01663090 | Soft Tissue Sar... | Ferumoxytol | 12 Years - | Dana-Farber Cancer Institute | |
| Novel Imaging Markers in SPMS | NCT05357833 | Secondary Progr... Multiple Sclero... Multiple Sclero... | Ferumoxytol inf... Gadoteridol MRI Brain and C... | 35 Years - 65 Years | University of Utah | |
| Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers | NCT02141490 | Prostate Cancer Bladder Cancer Kidney Cancer | Ferumoxytol Magnetic Resona... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer | NCT00087347 | Breast Cancer Prostate Cancer | ferumoxytol magnetic resona... | 18 Years - | Massachusetts General Hospital | |
| Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Stage IIB-IIIC Esophageal Cancer | NCT02857218 | Stage IIB Esoph... Stage III Esoph... Stage IIIA Esop... Stage IIIB Esop... Stage IIIC Esop... | Ferumoxytol Magnetic Resona... | 18 Years - | OHSU Knight Cancer Institute | |
| MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer | NCT02689401 | Esophageal Canc... | Ferumoxytol MRI 3T scanner | 18 Years - | Dana-Farber Cancer Institute | |
| Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases | NCT00103038 | Central Nervous... Malignant Gliom... Metastatic Mali... | 3 Tesla Magneti... Dynamic Contras... Dynamic Suscept... Ferumoxytol Gadolinium MRI-Based Angio... | 18 Years - | OHSU Knight Cancer Institute | |
| DCE MRI in Patients With Pancreatic Cancer | NCT02070705 | Familial Pancre... Pancreatic Aden... Pancreatic Intr... | Dynamic Contras... Ferumoxytol | 18 Years - 85 Years | OHSU Knight Cancer Institute | |
| Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy | NCT00769093 | Brain Neoplasms | Ferumoxytol | 18 Years - 75 Years | OHSU Knight Cancer Institute | |
| Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS | NCT02452216 | Brain Injury Central Nervous... Central Nervous... Central Nervous... Hemorrhagic Cer... Ischemic Cerebr... Primary Brain N... Brain Cancer Brain Tumors | Ferumoxytol Tissue Analysis Magnetic Resona... | 2 Years - | Stanford University | |
| Ferumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate Cancer | NCT01296139 | Prostate Cancer | Ferumoxytol | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI | NCT01895829 | Head and Neck C... | Magnetic Resona... Ferumoxytol | 18 Years - | M.D. Anderson Cancer Center | |
| In Vivo Characterization of Macrophages in Pediatric Patients With Malignant Brain Tumors Using Ferumoxytol-enhanced MRI | NCT03179449 | Childhood Brain... | Diagnostic (fer... Surgery Ferumoxytol Tissue Analysis | 2 Years - | Stanford University | |
| Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas | NCT01663090 | Soft Tissue Sar... | Ferumoxytol | 12 Years - | Dana-Farber Cancer Institute | |
| Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Locally Advanced Rectal Cancer | NCT03280277 | Locally Advance... Stage III Recta... Stage IIIA Rect... Stage IIIB Rect... Stage IIIC Rect... | Contrast-enhanc... Ferumoxytol | 18 Years - | OHSU Knight Cancer Institute | |
| MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer | NCT02689401 | Esophageal Canc... | Ferumoxytol MRI 3T scanner | 18 Years - | Dana-Farber Cancer Institute | |
| MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer | NCT02689401 | Esophageal Canc... | Ferumoxytol MRI 3T scanner | 18 Years - | Dana-Farber Cancer Institute | |
| Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases | NCT00103038 | Central Nervous... Malignant Gliom... Metastatic Mali... | 3 Tesla Magneti... Dynamic Contras... Dynamic Suscept... Ferumoxytol Gadolinium MRI-Based Angio... | 18 Years - | OHSU Knight Cancer Institute | |
| Diagnostic Accuracy of Ferumoxytol-Enhanced MRI for Detecting Lymph Node Metastases in Colorectal Cancer | NCT01983371 | Colorectal Canc... | Ferumoxytol Magnetic Resona... | 18 Years - | University of Vermont | |
| Ferumoxytol in Magnetic Resonance Imaging of Pediatric Patients With Brain Tumors | NCT03234309 | Brain Neoplasm | Ferumoxytol Magnetic Resona... | 5 Years - 18 Years | OHSU Knight Cancer Institute | |
| Novel Imaging Markers in SPMS | NCT05357833 | Secondary Progr... Multiple Sclero... Multiple Sclero... | Ferumoxytol inf... Gadoteridol MRI Brain and C... | 35 Years - 65 Years | University of Utah |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
